|
|
|
Home  All Products |
| All Products |
| CAS NO. |
Products Name |
| 1002304-34-8 |
AMG 208 |
more... |
| AMG 208 is a selective small-molecule inhibitor of the proto-oncogene c-Met with potential antineoplastic activity. c-Met inhibitor AMG 208 inhibits the ligand-dependent and ligand-inde... |
|
| 913376-83-7 |
AMG 458 |
more... |
| AMG 458 also inhibits HGF-mediated c-Met phosphorylation in PC3 and CT26 cells with IC50 of 60 and 120 nM.AMG 458 is observed to bind covalently to liver microsomal proteins from rats a... |
|
| 850879-09-3 |
Amuvatinib MP-470 |
more... |
| MP-470 is a multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Met, c-Kit, PDGFRalpha, Flt3, and c-Ret and with an IC50 of median 5 μM. MP-470 reduced c-Met ... |
|
| 1025720-94-8 |
BMS777607 |
more... |
| BMS 777607 is a Small-Molecule Met Kinase Inhibitor with an IC50 of < 0.1 μM.
Its treatment had little effect on tumor cell growth but inhibited cell scattering activated by exogenous... |
|
| 849217-64-7 |
Foretinib |
more... |
| Foretinib(GSK1363089, XL880) is a novel MET and VEGFR2/KDR kinases inhibitor with an IC50 of 0.4 and 0.8 nM for MET and KDR, respectively. Foretinib(GSK1363089, XL880) inhibits HGF rece... |
|
| 943540-75-8 |
JNJ 38877605 |
more... |
| JNJ-38877605 is an orally bioavailable, highly specific MET inhibitor (selective over other 229 kinases tested). This agent inhibits c-MET and Phospho-MET with IC50 at 4 nmol/L and 50 n... |
|
| 875337-44-3 |
MGCD-265 |
more... |
| MGCD265 is a tyrosine kinase inhibitor that targets the MET, VEGFR-1, VEGFR-2, VEGFR-3, RON and TIE2 receptor tyrosine kinases, which appear to play key roles in tumour development and ... |
|
| 1185763-69-2 |
NVP-BVU972 |
more... |
| NVP-BVU972 potently inhibits MET kinase but displays low inhibition against other kinases including the most closely related kinase RON with IC50 values of more than 1000 nM. NVP-BVU972... |
|
| 477575-56-7 |
PHA 665752 |
more... |
| PHA-665752 significantly inhibits c-Met kinase activity with Ki of 4 nM, and exhibits >50-fold selectivity for c-Met compared with various tyrosine and serine-threonine kinases. PHA-665... |
|
| 956905-27-4 |
PF-04217903 |
more... |
| PF-04217903 is an orally bioavailabe, small-molecule MET tyrosine kinase inhibitor with potential antineoplastic activity. PF-04217903 demonstrates exquisite kinase selectivity. Inhibit... |
|
|
|
|
Copyright © Taizhou Crene Biotechnology Co.,Ltd.
Close